Incorporating estimands into clinical trial statistical analysis plans
Kang M, Kendall MA, Ribaudo H, Tierney C, Zheng L, Smeaton L, Lindsey JC.
Clinical Trials. 2022. 19(3):285-291.
Links
Overview
Ph.D., Biostatistics
Harvard University, Cambridge, MA
Sc.B., Applied Mathematics
Brown University, Providence, RI
M.S., Operations Research
Cornell University, Ithaca, NY
Howard Hughes Medical Institute Predoctoral Fellowship in Biological Sciences
Bibliography
Effects of Sex, Existing Antibodies, and HIV-1-Related and Other Baseline Factors on Antibody Responses to Quadrivalent HPV Vaccine in Persons With HIV.
Kang M, Umbleja T, Ellsworth G, Aberg J, Wilkin T.
J Acquir Immune Defic Syndr. 2022 04 01. 89(4):414-422. PMID: 34907980
Continued Low Rates of Hepatitis C Virus (HCV) Recurrence in HCV/HIV- and HCV-Infected Participants Who Achieved Sustained Virologic Response After Direct-Acting Antiviral Treatment: Final Results From the AIDS Clinical Trials Group A5320 Viral Hepatitis C Infection Long-term Cohort Study (V-HICS).
Wyles DL, Kang M, Matining RM, Murphy RL, Peters MG.
Open Forum Infect Dis. 2021 Dec. 8(12):ofab511. PMID: 34926713
Early Progression and Immune Reconstitution Inflammatory Syndrome During Treatment of Mild-To-Moderate Kaposi Sarcoma in Sub-Saharan Africa and South America: Incidence, Long-Term Outcomes, and Effects of Early Chemotherapy.
Nyirenda M, Ngongondo M, Kang M, Umbleja T, Krown SE, Godfrey C, Samaneka W, Mngqibisa R, Hoagland B, Mwelase N, Caruso S, Martinez-Maza O, Dittmer DP, Borok M, Hosseinipour MC, Campbell TB.
J Acquir Immune Defic Syndr. 2020 08 01. 84(4):422-429. PMID: 32265361
Interim monitoring in a treatment strategy trial with a composite primary endpoint.
Kang M, Grund B, Hunsberger S, Glidden D, Volberding P.
Contemp Clin Trials. 2019 11. 86:105846. PMID: 31520741
PNPLA3 Gene Polymorphisms in HCV/HIV-Coinfected Individuals.
Sherman KE, Rouster SD, Kang M, Umbleja T, Sterling R, Butt AA.
Dig Dis Sci. 2018 11. 63(11):2969-2974. PMID: 30218427
Anogenital human papillomavirus virus DNA and sustained response to the quadrivalent HPV vaccine in women living with HIV-1.
Cespedes MS, Kang M, Kojic EM, Umbleja T, Godfrey C, Webster-Cyriaque JY, Masih R, Firnhaber C, Grinsztejn B, Saah A, Cu-Uvin S, Aberg JA.
Papillomavirus Res. 2018 12. 6:15-21. PMID: 30118852
As-Needed Vs Immediate Etoposide Chemotherapy in Combination With Antiretroviral Therapy for Mild-to-Moderate AIDS-Associated Kaposi Sarcoma in Resource-Limited Settings: A5264/AMC-067 Randomized Clinical Trial.
Hosseinipour MC, Kang M, Krown SE, Bukuru A, Umbleja T, Martin JN, Orem J, Godfrey C, Hoagland B, Mwelase N, Langat D, Nyirenda M, MacRae J, Borok M, Samaneka W, Moses A, Mngqbisa R, Busakhala N, Martínez-Maza O, Ambinder R, Dittmer DP, Nokta M, Campbell TB.
Clin Infect Dis. 2018 07 02. 67(2):251-260. PMID: 29365083
Similar Low Rates of HCV Recurrence in HCV/HIV- and HCV-Infected Participants who Achieved SVR After DAA Treatment: Interim Results From the ACTG A5320 Viral Hepatitis C Infection Long-term Cohort Study (V-HICS).
Wyles DL, Kang M, Matining RM, Murphy RL, Peters MG.
Open Forum Infect Dis. 2018 Jun. 5(6):ofy103. PMID: 29977962
Pre-vaccine plasma levels of soluble inflammatory indices negatively predict responses to HAV, HBV, and tetanus vaccines in HCV and HIV infection.
Shive CL, Judge CJ, Clagett B, Kalayjian RC, Osborn M, Sherman KE, Fichtenbaum C, Gandhi RT, Kang M, Popkin DL, Sieg SF, Lederman MM, Rodriguez B, Anthony DD.
Vaccine. 2018 01 25. 36(4):453-460. PMID: 29254840